Triamcinolone Acetonide Injection, Suspension
Product Images NDC 25021-054
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Triamcinolone Acetonide (NDC 25021-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – Vial Label (Tri0u 0000 02)
This is a product information for a medication with the code No. GUJ/DRUGS/G/28/1704. The medication is identified as Reonty with active ingredient Triamcinolone Acetonide Injectable Suspension. It contains 40 mg per mL and is intended for Intramuscular or Intra-articular use only. The medication is not suitable for IV, ID, intraocular, epidural, or intrathecal use. It is manufactured for SAGENT Pharmaceuticals and made in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.